Pivotal bioVenture Partners Investment Advisor LLC - Q1 2023 holdings

$243 Million is the total value of Pivotal bioVenture Partners Investment Advisor LLC's 11 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 10.0% .

 Value Shares↓ Weighting
KRTX BuyKARUNA THERAPEUTICS INC$142,043,933
-5.6%
782,008
+2.1%
58.49%
-10.6%
PCVX  VAXCYTE INC$25,975,102
-21.8%
693,0390.0%10.70%
-26.0%
INZY BuyINOZYME PHARMA INC$18,413,848
+559.0%
3,213,586
+20.8%
7.58%
+524.0%
NewOCULIS HOLDING AGordinary shares$17,692,2862,381,196
+100.0%
7.28%
 RALLYBIO CORP$13,730,517
-13.1%
2,404,6440.0%5.65%
-17.7%
ARQT  ARCUTIS BIOTHERAPEUTICS INC$6,259,451
-25.7%
569,0410.0%2.58%
-29.6%
FUSN SellFUSION PHARMACEUTICALS INC$5,884,902
+19.7%
1,560,982
-0.0%
2.42%
+13.3%
 VIGIL NEUROSCIENCE INC$5,488,225
-21.7%
560,5950.0%2.26%
-25.8%
 EXSCIENTIA PLCads$4,093,111
-0.6%
772,2850.0%1.68%
-5.9%
BOLT  BOLT BIOTHERAPEUTICS INC$2,629,139
+6.9%
1,891,4670.0%1.08%
+1.3%
ALGS  ALIGOS THERAPEUTICS INC$649,570
-8.3%
743,2150.0%0.27%
-13.3%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-05-12
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
KARUNA THERAPEUTICS INC12Q3 202365.4%
VAXCYTE INC12Q3 202319.5%
INOZYME PHARMA INC12Q3 202310.8%
ARCUTIS BIOTHERAPEUTICS INC12Q3 20236.2%
FUSION PHARMACEUTICALS INC12Q3 20236.2%
ALIGOS THERAPEUTICS INC12Q3 20238.0%
BOLT BIOTHERAPEUTICS INC11Q3 202320.0%
RALLYBIO CORP9Q3 202314.1%
AKOUOS INC8Q3 202211.7%
EXSCIENTIA PLC8Q3 20236.4%

View Pivotal bioVenture Partners Investment Advisor LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-12
13F-HR2023-02-13
13F-HR2022-11-10
13F-HR2022-08-12
13F-HR2022-05-13
13F-HR2022-02-14
13F-HR2021-11-15

View Pivotal bioVenture Partners Investment Advisor LLC's complete filings history.

Compare quarters

Export Pivotal bioVenture Partners Investment Advisor LLC's holdings